 |
 |
Hello, Is there anybody who has experience with the placebo-controlled medication-study (ACT5288) after the effect of SR57667B on Parkinson, done by Sanofi-Synthelabo. I am participating myself and I am anxious to hear about the experience of others. Reactions please to my private e-mail address ([log in to unmask]) greetings, rene helder ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn